Heuser, Christoph and Renner, Kathrin and Kreutz, Marina and Gattinoni, Luca (2023) Targeting lactate metabolism for cancer immunotherapy-a matter of precision. SEMINARS IN CANCER BIOLOGY, 88. pp. 32-45. ISSN 1044-579X, 1096-3650
Full text not available from this repository. (Request a copy)Abstract
Immune checkpoint inhibitors and adoptive T cell therapies have been valuable additions to the toolbox in the fight against cancer. These treatments have profoundly increased the number of patients with a realistic perspective toward a return to a cancer-free life. Yet, in a number of patients and tumor entities, cancer immunotherapies have been ineffective so far. In solid tumors, immune exclusion and the immunosuppressive tumor microenvironment represent substantial roadblocks to successful therapeutic outcomes. A major contributing factor to the depressed anti-tumor activity of immune cells in tumors is the harsh metabolic environment. Hypoxia, nutrient competition with tumor and stromal cells, and accumulating noxious waste products, including lactic acid, pose massive constraints to anti-tumor immune cells. Numerous strategies are being developed to exploit the metabolic vulnerabilities of tumor cells in the hope that these would also alleviate metabolism-inflicted immune suppression. While promising in principle, especially in combination with immunotherapies, these strategies need to be scrutinized for their effect on tumor-fighting immune cells, which share some of their key metabolic properties with tumor cells. Here, we provide an overview of strategies that seek to tackle lactate metabolism in tumor or immune cells to unleash anti-tumor immune responses, thereby opening therapeutic options for patients whose tumors are currently not treatable.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | T-CELL MEMORY; LACTIC-ACID; AEROBIC GLYCOLYSIS; TUMOR MICROENVIRONMENT; EFFECTOR RESPONSES; ANTITUMOR IMMUNITY; HIGH ACCUMULATION; DENDRITIC CELLS; INHIBITION; PROMOTES; Metabolism; Immunotherapy; Lactate; Adoptive cell transfer; Checkpoint inhibition; Glycolysis; Acidification |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 31 Jan 2024 11:21 |
| Last Modified: | 31 Jan 2024 11:21 |
| URI: | https://pred.uni-regensburg.de/id/eprint/56795 |
Actions (login required)
 |
View Item |
